We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Algeta Announces first US Patient Randomized in ALSYMPCA Phase III Study

News   Dec 16, 2009

 
Algeta Announces first US Patient Randomized in ALSYMPCA Phase III Study
 
 
 

RELATED ARTICLES

Shoulder Pain Relief for Wheelchair Users With Spinal Cord Injury

News

Researchers report initial results for a minimally invasive intervention for relief of chronic refractory shoulder pain in upper-limb dependent individuals with spinal cord injury.

READ MORE

Half of Ebola Outbreaks Go Undetected

News

The number of undetected Ebola outbreaks has been estimated, in a study published in PLOS Neglected Tropical Diseases.

READ MORE

Pre-Conception Risk Evaluation for Recurrence of Developmental Disorder in Future Pregnancies

News

Researchers present the PREGCARE study, which aims to provide healthy couples who have a child affected by a developmental disorder with a personalised pre-conception risk evaluation, at the European Society of Human Genetics annual conference.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE